1. AndersonD, PolitchJA, PudneyJ (2011) HIV infection and immune defense of the penis. Am J Reprod Immunol 65: 220–229.
2. AuvertB, TaljaardD, LagardeE, Sobngwi-TambekouJ, SittaR, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2: e298.
3. BaileyRC, MosesS, ParkerCB, AgotK, MacleanI, et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643–656.
4. GrayRH, KigoziG, SerwaddaD, MakumbiF, WatyaS, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657–666.
5. DinhMH, FahrbachKM, HopeTJ (2011) The role of the foreskin in HIV transmission: an evidence-based review. Am J Reprod Immunol 65: 279–283.
6. DonovalBA, LandayAL, MosesS, AgotK, Ndinya-AcholaJO, et al. (2006) HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 125: 386–391.
7. FischettiL, BarrySM, HopeTJ, ShattockRJ (2009) HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 23: 319–328.
8. GanorY, BomselM (2011) HIV-1 transmission in the male genital tract. Am J Reprod Immunol 65: 284–291.
9. GanorY, ZhouZ, TudorD, SchmittA, Vacher-LavenuMC, et al. (2010) Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol 3: 506–522.
10. JohnsonKE, ShermanME, SsempiijaV, TobianAA, ZenilmanJM, et al. (2009) Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS 23: 1807–1815.
11. ProdgerJL, GrayR, KigoziG, NalugodaF, GaliwangoR, et al. (2012) Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin. AIDS 26: 1319–1322.
12. QinQ, ZhengXY, WangYY, ShenHF, SunF, et al. (2009) Langerhans' cell density and degree of keratinization in foreskins of Chinese preschool boys and adults. Int Urol Nephrol 41: 747–753.
13. ZhouZ, Barry de LongchampsN, SchmittA, ZerbibM, Vacher-LavenuMC, et al. (2011) HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog 7: e1002100.
14. BoilyMC, BaggaleyRF, WangL, MasseB, WhiteRG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9: 118–129.
15. PowersKA, PooleC, PettiforAE, CohenMS (2008) Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 8: 553–563.
16. IqbalSM, KaulR (2008) Mucosal innate immunity as a determinant of HIV susceptibility. Am J Reprod Immunol 59: 44–54.
17. ColeAM (2005) Antimicrobial peptide microbicides targeting HIV. Protein Pept Lett 12: 41–47.
18. ColeAM, ColeAL (2008) Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reprod Immunol 59: 27–34.
19. ChangTL, VargasJJr, DelPortilloA, KlotmanME (2005) Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest 115: 765–773.
20. MackewiczCE, YuanJ, TranP, DiazL, MackE, et al. (2003) alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. Aids 17: F23–32.
21. BergmanP, Walter-JallowL, BrolidenK, AgerberthB, SoderlundJ (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5: 410–415.
22. MaG, Greenwell-WildT, LeiK, JinW, SwisherJ, et al. (2004) Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 200: 1337–1346.
23. PorterE, YangH, YavagalS, PrezaGC, MurilloO, et al. (2005) Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 73: 4823–4833.
24. PudneyJ, AndersonD (2011) Innate and acquired immunity in the human penile urethra. J Reprod Immunol 88: 219–227.
25. ProdgerJL, HirbodT, KigoziG, NalugodaF, ReynoldsSJ, et al. (2014) Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda. Mucosal Immunol 7: 634–644.
26. LevinsonP, KaulR, KimaniJ, NgugiE, MosesS, et al. (2009) Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 23: 309–317.
27. HasselrotK, SabergP, HirbodT, SoderlundJ, EhnlundM, et al. (2009) Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. AIDS 23: 329–333.
28. ChoiRY, LevinsonP, GuthrieBL, Lohman-PayneB, BosireR, et al. (2012) Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples. AIDS 26: 2155–2163.
29. DevitoC, BrolidenK, KaulR, SvenssonL, JohansenK, et al. (2000) Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 165: 5170–5176.
30. HirbodT, BrolidenK, KaulR (2008) Genital immunoglobulin A and HIV-1 protection: virus neutralization versus specificity. AIDS 22: 2401–2402.
31. FioreJR, LaddagoV, LeperaA, La GrastaL, Di StefanoM, et al. (2000) Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding. New Microbiol 23: 85–92.
32. HortonRE, BallTB, WachichiC, JaokoW, RutherfordWJ, et al. (2009) Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV. AIDS Res Hum Retroviruses 25: 83–92.
33. HirbodT, KaulR, ReichardC, KimaniJ, NgugiE, et al. (2008) HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 22: 727–735.
34. O'FarrellN, ChungCK, WeissHA (2008) Foreskin length in uncircumcised men is associated with subpreputial wetness. Int J STD AIDS 19: 821–823.
35. O'FarrellN, MorisonL, MoodleyP, PillayK, VanmaliT, et al. (2006) Association between HIV and subpreputial penile wetness in uncircumcised men in South Africa. J Acquir Immune Defic Syndr 43: 69–77.
36. JohanssonM, LyckeNY (2003) Immunology of the human genital tract. Curr Opin Infect Dis 16: 43–49.
37. PudneyJ, AndersonDJ (1995) Immunobiology of the human penile urethra. Am J Pathol 147: 155–165.
38. BelecL, GhysPD, HociniH, NkengasongJN, Tranchot-DialloJ, et al. (2001) Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. J Infect Dis 184: 1412–1422.
39. BomselM, PastoriC, TudorD, AlbertiC, GarciaS, et al. (2007) Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells. AIDS 21: 13–22.
40. ClericiM, BarassiC, DevitoC, PastoriC, PiconiS, et al. (2002) Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. Aids 16: 1731–1741.
41. LopalcoL, BarassiC, PastoriC, LonghiR, BurasteroSE, et al. (2000) CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro. J Immunol 164: 3426–3433.
42. MesteckyJ, WrightPF, LopalcoL, StaatsHF, KozlowskiPA, et al. (2011) Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women. AIDS Res Hum Retroviruses 27: 469–486.
43. KaleebuP, WhitworthJ, HamiltonL, RutebemberwaA, LyagobaF, et al. (2000) Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda. AIDS Res Hum Retroviruses 16: 393–401.
44. YirrellDL, KaleebuP, MorganD, WateraC, MagamboB, et al. (2002) Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda. AIDS 16: 279–286.
45. FurciL, SironiF, TolazziM, VassenaL, LussoP (2007) Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood 109: 2928–2935.
46. WangW, OwenSM, RudolphDL, ColeAM, HongT, et al. (2004) Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol 173: 515–520.
47. ChertovO, MichielDF, XuL, WangJM, TaniK, et al. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271: 2935–2940.
48. KaulR, BallTB, HirbodT (2011) Defining the genital immune correlates of protection against HIV acquisition: co-infections and other potential confounders. Sex Transm Infect 87: 125–130.
49. KaulR, RebbapragadaA, HirbodT, WachihiC, BallTB, et al. (2008) Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility. AIDS 22: 2049–2051.
50. TudorD, YuH, MaupetitJ, DrilletAS, BoucebaT, et al. (2012) Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody. Proc Natl Acad Sci U S A 109: 12680–12685.
51. WatkinsJD, SholukhAM, MukhtarMM, SiddappaNB, LakhasheSK, et al. (2013) Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission. AIDS 27: F13–20.
52. LizengQ, SkottP, SourialS, NilssonC, AnderssonSS, et al. (2003) Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection. Virology 308: 225–232.
53. HirbodT, KaulR, ReichardC, KimaniJ, NgugiE, et al. (2008) HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 22: 727–735.
54. SoderlundJ, HirbodT, GohLE, AnderssonJ, BrolidenK (2004) Presence of HIV-1 neutralizing IgA antibodies in primary HIV-1 infected patients. Scand J Infect Dis 36: 663–669.